Drug	Gene	Observed_DNA_Variant	Observed_Prot_Variant	Civic_Variant	Tier	Evidence_type	ct	Disease	Evidence
DASATINIB	ARID1A	c.1435C>T,c.4534C>T	p.Gln479Ter,p.Gln1512Ter	P1175FS*5	tier_3	PREDICTIVE	nct	OVARIAN CLEAR CELL CARCINOMA	{'SUPPORTS:SENSITIVITYRESPONSE': {'D': ['PUBMED_27364904:ACCEPTED:ACCEPTED:SOMATIC:2']}}
NERATINIB	ERBB2	c.2033G>A	p.Arg678Gln	R678Q	tier_1	PREDICTIVE	nct	BREAST CANCER	{'SUPPORTS:SENSITIVITYRESPONSE': {'D': ['PUBMED_23220880:ACCEPTED:ACCEPTED:SOMATIC:5']}}
LAPATINIB	ERBB2	c.2033G>A	p.Arg678Gln	R678Q	tier_1	PREDICTIVE	nct	BREAST CANCER	{'SUPPORTS:SENSITIVITYRESPONSE': {'D': ['PUBMED_23220880:ACCEPTED:ACCEPTED:SOMATIC:5']}}
AFATINIB	ERBB3	c.308G>A,c.310G>T	p.Arg103His,p.Val104Leu	R103G	tier_2	PREDICTIVE	nct	TRANSITIONAL CELL CARCINOMA	{'SUPPORTS:SENSITIVITYRESPONSE': {'B': ['PUBMED_27044931:ACCEPTED:ACCEPTED:SOMATIC:3']}}
